Opus Genetics (IRD) Depreciation & Amortization - Total (2011 - 2014)
Powered by 
Analysis
Opus Genetics (IRD) Depreciation & Amortization - Total (2011 - 2014) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Opus Genetics | 446.86 Mn | 358.05 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2014 | 3,744.00 |
| Jun 30, 2014 | 9,630.00 |
| Mar 31, 2014 | 9,044.00 |
| Dec 31, 2013 | 8,937.00 |
| Sep 30, 2013 | 9,645.00 |
| Jun 30, 2013 | 9,235.00 |
| Mar 31, 2013 | 9,316.00 |
| Dec 31, 2012 | 10,223.00 |
| Sep 30, 2012 | 10,721.00 |
| Jun 30, 2012 | 10,721.00 |
| Mar 31, 2012 | 10,721.00 |
| Dec 31, 2011 | 10,166.00 |
| Sep 30, 2011 | 10,127.00 |
| Jun 30, 2011 | 10,650.00 |